Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma

by Wei Deng, MD, Krishan R. Jethwa, MD, Karthik Gonuguntla, MD, Zhongxing Liao, MD, Harry H. Yoon, MD, Mariela Blum Murphy, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD, Steven H. Lin, MD PhD
Published 2020-09-01

Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related a...

by Krishan R. Jethwa, MD, Erik J. Tryggestad, PhD, Thomas J. Whitaker, PhD, Broc T. Giffey, CMD, Bret D. Kazemba, CMD, Michelle A. Neben-Wittich, MD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD
Published 2018-07-01

Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer

by Elizabeth B. Jeans, MEd, MD, Krishan R. Jethwa, MD, William S. Harmsen, MS, Michelle Neben-Wittich, MD, Jonathan B. Ashman, MD, Kenneth W. Merrell, MD, Broc Giffey, CMD, Shima Ito, MS, Bret Kazemba, CMD, Chris Beltran, PhD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD
Published 2020-09-01

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience

by Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD
Published 2021-07-01

Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus

by Jahan J. Mohiuddin, MD, Krishan R. Jethwa, MD, Nikhil Grandhi, BS, William G. Breen, MD, Xingmei Wang, MS, Akbar Anvari, PhD, Hui Lin, PhD, Harigopal Sandhyavenu, MBBS, Abigail Doucette, MPH, John P. Plastaras, MD, PhD, William G. Rule, MD, James M. Metz, MD, Kenneth W. Merrell, MD, Terence T. Sio, MD, Jonathan B. Ashman, MD, PhD, Michael G. Haddock, MD, Edgar Ben-Josef, MD, Christopher L. Hallemeier, MD, Andrzej P. Wojcieszynski, MD
Published 2021-09-01

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704

by William F. Regine, MD, Kathryn Winter, MS, Ross A. Abrams, MD, Howard Safran, MD, Ivan L. Kessel, MD, Yuhchyau Chen, MD, PhD, James A. Fugazzi, MD, Eric D. Donnelly, MD, Thomas A. DiPetrillo, MD, Samir Narayan, MD, John P. Plastaras, MD, Rakesh Gaur, MD, Guila Delouya, MD, John H. Suh, MD, Joshua E. Meyer, MD, Michael G. Haddock, MD, Mukund S. Didolkar, MD, Gilbert D.A. Padula, MD, David Johnson, MD, John P. Hoffman, MD, Christopher H. Crane, MD
Published 2018-04-01